α2-Macroglobulin Is a Novel Substrate for ADAMTS-4 and ADAMTS-5 and Represents an Endogenous Inhibitor of These Enzymes
Micky D. Tortorella(Pfizer (United States)), Anne‐Marie Malfait(Rush University Medical Center), Alan M. Easton(Pfizer (United States)), Jennifer Korte-Sarfaty(Pfizer (United States)), Elizabeth C. Arner(DuPont (United States)), Rui‐Qin Liu(Wilmington University), Arthur J. Wittwer(Pfizer (United States)), Kam F. Fok(Pfizer (United States)), Robert L. Hills(Pfizer (United States))
Cited by 141
Related Papers
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
|Proceedings of the National Academy of Sciences|2000|662
Cloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS Family
|Journal of Biological Chemistry|1999|488
Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS‐4 and ADAMTS‐5
|Arthritis & Rheumatism|2007|403
The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation
|Osteoarthritis and Cartilage|2001|324
Osteoarthritis joint pain: The cytokine connection
|Cytokine|2014|321